Retinal diseases: RNA therapeutics show promise but is India ready?

There is currently no large cohort study in India, i.e. involving at least 500 patients, to describe the mutation spectrum of IRDs. Such extensive studies are vital for researchers to identify the most common genetic defects that can subsequently be targeted using precision medicineThere is currently no large cohort study in India, i.e. involving at least 500 patients, to describe the mutation spectrum of IRDs. Such extensive studies are vital for researchers to identify the most common genetic defects that can subsequently be targeted using precision medicine There is currently no large cohort study in India, i.e. involving at least 500 patients, to describe the mutation spectrum of IRDs. Such extensive studies are vital for researchers to identify the most common genetic defects that can subsequently be targeted using precision medicine Science Science News | Latest Updates on Scientific Discoveries | The Hindu